Shawn Sills, MD
Pain Medicine · Medford, ORNPI 1245239375
Payments from drug & device makers
Across 495 payments — averaging $3739.24 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Nevro Corp.$1.7M
- Globus Medical$137K
- Medtronic$17K
- Saluda Medical Americas, Inc.$3K
- Abbott$2K
- Stimwave Technologies Incorporated$1K
- plus $2K from 21 others
What the payments were for
- Travel & lodging$16,45159%
- Food & beverage$11,50641%
- Education$80%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Nevro Corp. | 150 | $1,688,058 |
| Globus Medical | 48 | $137,309 |
| Medtronic(2 entities) | 146 | $16,890 |
| Saluda Medical Americas, Inc. | 21 | $3,205 |
| Abbott | 26 | $1,968 |
| Stimwave Technologies Incorporated | 9 | $1,167 |
| Nalu Medical, Inc. | 17 | $470 |
| Boston Scientific | 8 | $424 |
| Collegium Pharmaceutical, Inc. | 31 | $412 |
| Vertos Medical, Inc. | 2 | $165 |
| SPR Therapeutics, Inc | 2 | $160 |
| AbbVie | 5 | $87 |
| Si-bone, Inc. | 2 | $85 |
| GRT US Holding, Inc. | 5 | $78 |
| Indivior Inc. | 1 | $74 |
| Pfizer | 4 | $56 |
| Vanda Pharmaceuticals Inc. | 2 | $53 |
| Pacira Therapeutics, Inc. | 2 | $48 |
| MDD US Operations, LLC | 3 | $37 |
| Avanos Medical | 2 | $31 |
| Curonix LLC | 2 | $30 |
| Averitas Pharma Inc. | 1 | $28 |
| Stryker | 1 | $27 |
| Biodelivery Sciences International, Inc. | 2 | $25 |
| Vertex | 1 | $14 |
| Painteq LLC | 1 | $14 |
| Daiichi Sankyo Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- SYNCHROMEDII$2,895
- Evoke$2,516
- INTELLIS ADAPTIVESTIM$1,958
- OSTEOCOOL RF ABLATION$1,680
- OSTEOCOOL RF ABLATION SYSTEM$1,577
- VANTA ADAPTIVESTIM$1,557
- KYPHON EXPRESS II KYPHOPAK TRAY$1,154
- SYNCHROMED$1,047
- Axium$1,001
- SCS FreedonSpinal Cord Stimulator$987
- CFNS StimQ Peripheral Nerve StimulatorSystem$864
- Vanta$780
- Senza$344
- PROCLAIM$326
- Nalu Neurostimulation System$263
- Senza Spinal Cord Stimulation System$196
- StimQ Peripheral Nerve StimulatorSystem$123
How this compares
$1,850,926 in reported general payments places this provider in the 95th percentile of 57 pain medicine providers in Oregon.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 36 | $635 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 30 | $323 |
| Oxycodone Hcl | 13 | $276 |
| Gabapentin | 21 | $238 |
| Hydromorphone Hcl | 15 | $129 |
| Mupirocin | 11 | $93 |
| Doxycycline Monohydrate | 12 | $48 |
Paid to pharmacies, not to this prescriber.
Other pain medicine in Medford
- Joseph SavinoMedford$244K
- Brett QuaveMedford$12K
- Alan HsuMedford$5K
- Robert HerosTualatin$1.8M
- Vishal KhemlaniTualatin$1.2M
- Sandy ChristiansenPortland$103K
- Kimberly MauerPortland$71K
- David RussoHood River$49K
- Andrew OhPortland$36K
- Stuart RosenblumPortland$31K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.